-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

732.P1.58 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster I

Symposia: Allogeneic Transplantation: Disease Response and Comparative Treatment Studies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Bingqian Jiang1*, Tingting Yang1*, Yi Luo1, Yanmin Zhao1*, Guifang Ouyang2*, Jian Yu1*, Jianping Lan3*, Ying Lu4*, Xiaoyu Lai1*, Baodong Ye, MD5*, Yi Chen6*, Lizhen Liu1*, Yang Xu7*, Pengfei Shi8*, Haowen Xiao9*, Huixian Hu10*, Qunyi Guo11*, Huarui Fu1*, Yishan Ye, MD1*, Xinyu Wang1*, Jie Sun1*, Weiyan Zheng, MD1*, Jingsong He12*, Yi Zhao1*, Wenjun Wu1*, Zhen Cai1*, Guoqing Wei1*, He Huang1* and Jimin Shi1*

1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Department of Hematology, Ningbo First Hospital, Ningbo, China
3Department of Hematology, Zhejiang Provincial People’s Hospital, Hangzhou, China
4Department of Hematology, Yinzhou People's Hospital, Ningbo, China
5The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
6Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
7The Second Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China
8Department of Hematology, The Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
9Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China
10Department of Hematology, Jinhua Central Hospital, Jinhua, China
11Department of Hematology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical College, Taizhou, China
12The Department of Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Junjie Chen1*, Zhixiang Wang1*, Qifa Liu, MD2 and Hongsheng Zhou3,4*

1Southern Medical University/Hematology department, Guangzhou, China
2Department of Hematology, Nanfang Hospital, Southern medical university CN, Guangzhou, China
3Nanfang Hospital, Southern Medical University, Guangzhou, China
4Nanfang Hospital, Southern Medical University, Guangzhou, CHN

Arpita Gandhi, MD1, Rasmus T. Hoeg, MD2*, Sagar S. Patel, MD3, Edmund K. Waller, MD4, Jeremy M. Pantin, MD5*, Caspian H. Oliai, MD6, J. Scott McClellan, MD, PhD7, Anna Pavlova, MD, PhD8, Irene Agodoa, MD7, Nathaniel B. Fernhoff, PhD7* and Everett H. Meyer, MD, PhD9

1Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
2Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis, Sacramento, CA
3Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
4Winship Cancer Institute, Emory University, Atlanta, GA
5Sarah Cannon Transplant and Cellular Therapy Program, Department of Hematopoietic Cell Therapy, TriStar Centennial Medical Center, Nashville, TN
6Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA
7Orca Bio, Menlo Park, CA
8Orcabio, Menlo Park, CA
9Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University Medical Center, Stanford, CA

Jan Christian Schröder, MD1*, Jan Frederic Weller, MD2*, Philipp Faustmann, MD2*, Lucas Mix, MD2*, Christoph Faul, MD1, Claudia Lengerke, MD1 and Wolfgang Andreas Bethge, MD1*

1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
2Department for Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany

Christine Camacho-Bydume, MD1, Tao Wang, PhD2*, Diego Chowell, PhD3*, Chirag Krishna, PhD4*, Brian C. Shaffer, MD5,6, Steven Marsh, BSc, ARCS, PhD, FRCPath7*, Sophie Paczesny8, Shahinaz M. Gadalla, MD, PhD9, Meilun He, MPH10*, Yung-Tsi Bolon, PhD10*, Stephen R. Spellman, MBS11*, Stephanie J. Lee12 and Katharine C. Hsu, MD, PhD13

1Pediatric Hematology/Oncology/BMT, Hackensack University Medical Center, Hackensack, NJ
2Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
3Icahn School of Medicine at Mount Sinai, New York, NY
4Broad Institute of MIT and Harvard, Cambridge, MA
5Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
6Department of Medicine, Weill Cornell Medicine, New York
7Anthony Nolan Research Institute, London, GBR
8Medical University of South Carolina, Charleston, SC
9Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD
10CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis
11CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
12Fred Hutchinson Cancer Center, Seattle, WA
13Memorial Sloan Kettering Cancer Center, New York, NY

Frederic Baron, MD, PhD1, Myriam Labopin2,3*, Jurjen Versluis, MD, PhD4*, Jan Vydra5*, Peter A. Von Dem Borne, MD, PhD6*, Emma Nicholson, MD, PhD7*, Didier Blaise8*, Stephen Robinson Jr.9*, Aleksandr Kulagin Sr.10*, Claude-Éric Bulabois, MD11*, Montserrat Rovira, MD, PhD12*, Patrice Chevallier, MD13, Édouard Forcade14*, Jenny Louise Byrne, MD, PhD15*, Jaime Sanz Caballer, MD, PhD16*, Annalisa Ruggeri, MD, PhD17*, Mohamad Mohty, MD, PhD18 and Fabio Ciceri19*

1University of Liege, Liege, Belgium
2EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
3Hôpital Saint-Antoine, Université Sorbonne, INSERM UMRs 938, Paris, France
4Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, Netherlands
5Institute of Hematology and Blood Transfusion, Prague, Czech Republic
6Hematology, Leiden University Medical Center, Leiden, Netherlands
7Department of Haematology, Royal Marsden Hospital, London, United Kingdom
8Institut Paoli-Calmettes, Aix Marseille Université, Management Sport Cancer Laboratoire (MSC), Marseille, France
9University Hospitals Bristol, Bristol, GBR
10b. First State Pavlov Medical University of St. Petersburg, Raisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Hematology, and Transplantation, St-Petersburg, Russia, St. Petersburg, RUS
11Hématologie Soins Intensifs, CHU Grenoble Alpes, Grenoble, France
12Hospital Clínic de Barcelona, Barcelona, Spain
13Service d'hématologie, CHU de Nantes, Nantes, France
14Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, F-33000, Bordeaux, France
15Nottingham University, Nottingham, ENG, GBR
16Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Valencia, ESP
17Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
18Department of Haematology and EBMT Paris study office / CEREST-TC, Saint Antoine Hospital, INSERM UMR 938 and Université Pierre et Marie Curie, Paris, France
19Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy

Ali Bazarbachi, MD, PhD1, Myriam Labopin2*, Iman Abou Dalle, MD3*, Ibrahim Yakoub-Agha, MD, PhD4*, Regis Peffault De Latour5*, Thomas Schroeder6*, Didier Blaise, MD, PhD7, Xavier Poire, MD8*, Marie Balsat, MD9*, Urpu Salmenniemi10*, Nicolaus Kröger, MD11*, Aleksandr Kulagin Sr.12*, Eva Wagner Drouet, MD13*, Depei Wu14, Eolia Brissot15*, Arnon Nagler, MD16, Sebastian Giebel17*, Fabio Ciceri18* and Mohamad Mohty, MD, PhD19

1American University of Beirut Dept. of Medicine, Beirut, Lebanon
2EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
3Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut medical center, Beirut, Lebanon
4CHU de Lille, Université de Lille, INSERM U1286, Infinite, 59000, Lille, France
5Hôpital Saint-Louis,, Paris, France
6Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
7Program of Transplant and cellular immunotherapy, Department of Hematology, Institut Paoli Calmettes, Marseille, France
8Section of hematology, Institut Roi Albert II, Cliniques Universitaires St-Luc, Brussels, Belgium
9Clinical Hematology Department, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France, Lyon, France
10Dept of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
11University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany
12b. First State Pavlov Medical University of St. Petersburg, Raisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Hematology, and Transplantation, St-Petersburg, Russia, St. Petersburg, RUS
13University Medicine Mainz, Mainz, Germany
14The First Affiliated Hospital of Soochow University, Suzhou, China
15Sorbonne Université Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Centre de Recherche Saint-Antoine (CRSA), Paris, France
16Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel
17Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
18Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy
19Saint-Antoine Hospital, Sorbonne University, Paris, France

Yves Chalandon, MD1, Raynier Devillier, MD, PhD2*, Ariane Boumendil3*, Stéphanie Nguyen Quoc, MD, PhD4*, Claude-Eric Bulabois, MD5*, Patrice Ceballos, MD6*, Eolia Brissot7*, Marie Thérèse Rubio, MD, PhD8*, Hélène Labussière-Wallet, MD9*, Johan Maertens, MD, PhD10*, Patrice Chevallier, MD11, Natacha Maillard, MD12*, Xavier Poiré, MD13*, Cristina Castilla-Llorente, MD14*, Prof. Yves Beguin, MD15*, Jérôme Cornillon, MD16*, Sebastien Maury17*, Tony Marchand, MD18*, Etienne Daguindau19*, Jacques-Olivier Bay, MD, PhD20*, Pascal Turlure, MD21*, Amandine Charbonnier, MD22*, Anne Menard, MD23*, Karin Bilger, MD24*, Gaelle Guillerm25*, Sylvie François, MD26*, Ali Bazarbachi, MD, PhD27, Sylvain Chantepie, MD28*, Philippe Lewalle Sr., MD29*, Ambroise Marcais, MD30*, Michael Loschi, MD, PhD31*, Malek Benakli, MD32*, Paul Chauvet, MD33*, Edouard Forcade, MD, PhD34*, Anne Huynh, MD35*, Marie Robin, MD, PhD36* and Stavroula Masouridi-Levrat, MD37*

1Univ. Hospital of Geneva, Geneva, Switzerland
2Institut Paoli-Calmettes, Marseille, France
3Société Francophone de Greffe de moelle et Thérapie Cellulaire (SFGM-TC), Paris, France
4Hematology Department, Sorbonne Université, Hôpital Pitié-Salpêtrière, APHP, Paris, France
5Hématologie Soins Intensifs, CHU Grenoble Alpes, Grenoble, France
6Clinical Hematology Department, Montpellier University Hospital, MONTPELLIER, France
7Hôpital Saint-Antoine, Sorbonne University, INSERM UMRs 938, Paris, France
8Nancy University Hospital, Vandoeuvre Les Nancy, FRA
9Centre Hospitalier Lyon Sud, Lyon, France
10Department of Hematology, University Hospitals Leuven, Leuven, Belgium
11Service d'hématologie, CHU de Nantes, Nantes, France
12Hematology Department, CHU de Poitiers, Poitiers, France
13Section of hematology, Institut Roi Albert II, Cliniques Universitaires St-Luc, Brussels, Belgium
14Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France
15Service d'Hématologie, CHU de Liège, Liege, BEL
16Hématologie, CHU de Saint-Etienne, Saint-Etienne, France
17Hematology Department, Hôpitaux universitaires Henri Mondor AP-HP & Université Paris Est Créteil, Créteil, France
18Hematology Department, CHU Rennes, Rennes, France
19Department of Clinical Hematology, CHU de Besançon, Besançon, France
20Service d’hématologie, CHU Clermont-Ferrand, Clermont-Ferrand, France
21Service d'Hématologie Clinique, CHU de Limoges, Limoges, France
22Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
23Centre Henri Becquerel, Rouen, FRA
24Hematology, Institut de Cancerologie Strasbourg Europe (ICANS), Strasbourg, France
25Service d'hématologie, Hôpital Morvan, CHRU Brest, Brest, France
26Maladies du sang, CHU Angers, Angers, France
27American University of Beirut Dept. of Medicine, Beirut, Lebanon
28Institut d'Hématologie, CHU de Caen, Caen, France
29Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Hematology Department, Brussels, BEL
30Hôpital Necker, AP-HP, PARIS, France
31Centre Hospitalier Universitaire de Nice, Nice, France
32CPMC d’Alger, Alger, Algeria
33Maladies du Sang, Université de Lille,, CHU de Lille,, Lille, FRA
34Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Pessac, France
35Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
36Hopital Saint Louis, Paris, France
37Hematology Service and Faculty of Medicine, University Hospital of Geneva, Geneva, Switzerland

Desiree Kunadt1*, Sven Zukunft1*, Klaus H Metzeler, MD2,3, Christoph Röllig, MD, MSc1*, Christoph Schliemann, MD4*, Jan Braess, MD5*, Carsten Müller-Tidow, MD6*, Alwin Kraemer7*, Sebastian Scholl, MD8*, Inken Hilgendorf, MD9*, Edgar Jost, MD10*, Björn Steffen, MD11*, Gesine Bug, MD12*, Hermann Einsele, MD, PhD13*, Kerstin Schäfer-Eckart, MD14*, Stefan W. Krause, MD15*, Mathias Hänel, MD16, Thomas Schroeder17*, Martin Kaufmann, MD18, Jan Moritz Middeke, MD19*, Katja Sockel, MD19*, Leo Ruhnke, MD1*, Uwe Platzbecker, MD20, Hubert Serve, MD11, Matthias Stelljes, MD21, Claudia D Baldus, MD22*, Andreas Neubauer, MD23, Johannes Schetelig, MD, MSc24,25, David Poitz26*, Christian Thiede, MD27, Martin Bornhäuser, MD28,29* and Friedrich Stölzel, MD30,31*

1Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
2Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, NA, Germany
3Department of Internal Medicine III, Experimental Leukemia and Lymphoma Research (ELLF), University Hospital, LMU Munich, Munich, Germany
4Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
5Hospital Barmherzige Brueder Regensburg, Regensburg, Germany
6Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
7Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany, Heidelberg, DEU
8Klinik für Innere Medizin II, Jena University Hospital, Jena, Germany
9Universitätsklinikum Jena, Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Jena, Germany
10Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
11Department of Internal Medicine II, Hematology and Oncology, Goethe University Hospital Frankfurt, Frankfurt, Germany
12Dept. of Medicine 2, Goethe University, University Hospital, Frankfurt, Germany
13Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
14Department of Internal Medicine V, Paracelsus University Hospital Nuremberg, Nuremberg, Germany
15Universitätsklinikum Erlangen, Erlangen, Germany
16Department of Internal Medicine III, Hematology, Oncology and Cellular Therapies, Hospital Chemnitz, Chemnitz, Germany
17Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
18Department of Hematology, Oncology and Palliative Care, Robert Bosch Hospital, Stuttgart, Germany
19Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
20University Leipzig Medical Center, Leipzig, Germany
21Department of Internal Medicine A, University of Muenster, Muenster, Germany
22University Hospital Schleswig-Holstein, Department of Hematology and Oncology, Campus Kiel, Kiel, Germany
23Department of Hematology, Oncology and Immunology, Phillips-University Marburg, Marburg, Germany, Marburg, Germany
24TU Dresden, Dresden, Saxony, Germany
25DKMS Group gGmbH, Dresden, Germany
26Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Dresden, TU Dresden, Germany, Dresden, Germany
27Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
28National Center for Tumor Diseases (NCT/UCC) Dresden, Technical University Dresden, Dresden, Germany
29Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
30Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
31Department of Internal Medicine, University Hospital Carl Gustav Carus, Dresden, DEU

Jean Elcheikh, MD1,2*, Maud Ngoya3*, Jacques-Emmanuel Galimard4*, Péter Reményi, MD5*, Aleksandr Kulagin Sr.6*, Mahmoud Aljurf, MD7*, Ashrafsadat Mousavi8*, Depei Wu9, Mutlu Arat10, Urpu Salmenniemi11*, Cristina Castilla-Llorente, MD12*, Gerard Socié13, Grzegorz Helbig, MD, PhD14*, Thomas Schröder, MD15*, Ioanna Sakellari16*, Alessandro Rambaldi, M.D.17,18, Ben Carpenter, MD, PhD19*, Alessandro Busca20*, Helene Labussiere Wallet21*, Matthias Stelljes, MD22, Eolia Brissot23*, Sebastian Giebel24*, Zina Peric, MD, PhD25*, Arnon Nagler, MD26, Fabio Ciceri27*, Ali Bazarbachi, MD, PhD28 and Mohamad Mohty, MD, PhD29

1Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beiurt, Lebanon
2Bone Marrow Transplantation Program and Division of Hematology and oncology, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon, beirut, Lebanon
3EBMT ALWP Statistical Unit, Saint Antoine Hospital, Sorbonne University, Paris., Paris, France
4EBMT ALWP Statistical Unit, Saint Antoine Hospital, Sorbonne University, Paris, Paris, France
5Department of Hematology and Stem Cell Transplantation, South-Pest Central Hospital, Budapest, Hungary
6b. First State Pavlov Medical University of St. Petersburg, Raisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Hematology, and Transplantation, St-Petersburg, Russia, St. Petersburg, RUS
7Dept of Hematology, Stem Cell Transplantation and Cellular Therapy , KFSHRC, Riyadh, Saudi Arabia
8Shariati Hospital, Hematology-Oncology and BMT Research – Teheran, Iran, Teheran, Iran (Islamic Republic of)
9The First Affiliated Hospital of Soochow University, Suzhou, China
10İstanbul Florence Nightingale Hospital, Hematology Department, İstanbul, Turkey
11Dept of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
12Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France
13Hopital St. Louis, Department of Hematology - BMT, Paris, France
14Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland
15Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany
16George Papanicolaou General Hospital, Haematology Department / BMT Unit – Thessaloniki, Greece, Thessaloniki, Greece
17Department of Oncology and Hematology, University of Milan and Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo BG, Italy
18Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
19University College London Hospitals NHS Foundation Trust, London, United Kingdom
20S.S.C.V.D Trapianto di Cellule Staminali, A.O.U Citta della Salute e della Scienza di Torino – Torino, Italy, Torino, Italy
21Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
22Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
23Sorbonne Université Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Centre de Recherche Saint-Antoine (CRSA), Paris, France
24Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
25School of Medicine, University Hospital Centre Zagreb, University of Zagreb, Zagreb, Croatia
26Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel
27Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy
28American University of Beirut Dept. of Medicine, Beirut, Lebanon
29Sorbonne University, Clinical Hematology and Cellular Therapy Department, , Saint Antoine Hospital, INSERM UMRs 938, Paris., Paris, France

Hyung C Suh, MD/PhD1, Amy Einstein, MSN, APN2*, Addi Georgantzis, MSN, APN2*, Phyllis McKiernan, MSN, APN2*, Melissa Baker, DNP2*, Michele S Boonstra, MSN, APN2*, Sukhdeep Kaur, MD3*, Christina Cho, MD2, Scott D Rowley, MD2 and Michele L. Donato, MD2

1Stem Cell Transplantation and Cellular Therapy Program, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
2Stem Cell Transplantation and Cellular Therapy Program, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
3Stem Cell Transplantation and Cellular Therapy Program, John Theurer Cancer Center, Hackensack Meridian Health, New Brunswick, NJ

Joanne BL Tan1, David J. Curtis, MBBS, PhD2, Jenny Muirhead1*, Michael Swain3*, Shaun Fleming4*, BIanca Cirone1*, Maureen O'Brien3*, Shu Min Wong1*, Shafqat Inam5*, Sushrut S. Patil1* and Andrew Spencer, MBBS, MD, FRACP, FRCPA6*

1Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, VIC, Australia
2Monash University, Melbourne, VIC, AUS
3Alfred Health, Melbourne, AUS
4Alfred Health, Melbourne, Australia
5Department of malignant haematology and stem cell transplantation, The Alfred Hospital, Prahran, Australia
6Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia

Scott R. Solomon, MD1, Michael T Aubrey2*, Lizamarie Bachier-Rodriguez, MD1*, Melhem M. Solh, MD1, Katelin C Jackson1*, Xu Zhang, PhD3*, Christina Roark2*, H. Kent Holland, MD1*, Lawrence Morris, MD1 and Asad Bashey, MD, PhD1

1Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
2University of Colorado Cord Blood Bank & Clinimmune Lab, Aurora, CO
3Center for Clinical and Transitional Sciences,, University of Texas, Houston, TX

Karam Ashouri, MD1, Brian Hom1*, Mollee Chu, MD1*, Jennifer Hwang, MD1*, Karen Resnick, MD1*, Yekta Rahimi, MD1*, Robert Ireland, MD1*, Anush Aram Ginosyan, MD1*, Eljie Isaak Bragasin1*, Preet M. Chaudhary, MD, PhD2, Karrune Woan, MD, PhD2*, Imran Siddiqi, MD, PhD2*, Abdullah Ladha, MD2*, Amir Ali, PharmD, BCOP2 and George Yaghmour, MD2

1Keck School of Medicine, University of Southern California, Los Angeles, CA
2Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA

Muhammad Kashif Amin, MD1*, Moazzam Shahzad, MD2, Joe S. Al-Ramahi3*, Shaun DeJarnette3*, Forat Lutfi, MD3*, Nausheen Ahmed, MD4,5, Haitham Abdelhakim, MD3, Rajat Bansal, MD3*, Leyla Shune, MD5,6, Al-Ola Abdallah, MD5,6, Anurag K. Singh, MD3, Sunil Abhyankar, MD3, Joseph P McGuirk, DO3,5 and Muhammad Umair Mushtaq, MD5,6

1University of Kansas Medical Center, Kansas City, KS
2H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3University of Kansas Medical Center, Westwood, KS
4University of Kansas Cancer Center, Westwood, KS
5US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
6Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS

Bingqian Jiang1*, Yanmin Zhao1*, Yi Luo1*, Jian Yu1*, Yi Chen2*, Baodong Ye, MD3*, Huarui Fu1*, Xiaoyu Lai1*, Lizhen Liu1*, Yishan Ye, MD1*, Weiyan Zheng, MD1*, Jie Sun1*, Jingsong He4*, Yi Zhao1*, Guoqing Wei1*, Zhen Cai1*, He Huang1* and Jimin Shi1*

1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
3The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
4The Department of Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Jule Ussmann1*, Anne Weigert, PhD1*, Lara Bischof1*, Dominic Brauer, MD1*, Donata Backhaus, MD1*, Claudia Diener1*, Maximilian Merz, MD1, Vladan Vucinic, M.D.2*, Klaus H Metzeler, MD3, Uwe Platzbecker, MD4, Sebastian Schwind, MD1* and Madlen Jentzsch1*

1Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
2Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
3Department of Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
4Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig, Germany

Shivani Sharma, MBBS1, Arcita Hanjani Pramudita, MD2*, Suma Sri Chennapragada, MD3, Hemamalini Sakthivel, MD4*, Poornima Ramadas, MD5, Kamleshun Ramphul, MD6* and Roman M. Shapiro, MD7

1Assistant Professor Clinical of Internal Medicine, Louisiana State University Health Shreveport, Shreveport, LA
2Harvard Medical School/Dana-Farber Cancer Institute, Boston, MA
3LSUHSC-S/Feist-Weiller Cancer Center, Shreveport, LA
4One Brooklyn Health System/Interfaith Medical Center Program, Brooklyn, NY, USA., New York
5Feist-Weiller Cancer Center, LSU Health Shreveport, Shreveport, LA
6Independent Researcher, Triolet, Mauritius
7Dana-Farber Cancer Institute, Boston, MA

Stacey M Frumm, md1*, Haesook T. Kim, PhD2, Amar H Kelkar, MD2, Vincent T. Ho, MD3*, Mahasweta Gooptu, MD4, Christopher James Gibson, MD2, John Koreth, MD, MBBS, PhD, DPhil2, Roman M. Shapiro, MD2, Rizwan Romee, MD5, Sarah Nikiforow, MD, PhD2, Joseph H. Antin, MD6, Robert J. Soiffer, MD3, Benjamin Rolles, MD7, Shai Shimony, MD8*, Jan Philipp Bewersdorf, MD9, Tariq Kewan, MBBChir10, Abdulrahman Alhajahjeh, MD11*, Marlise R. Luskin, MD, MSCE2, Jacqueline S. Garcia, MD8, Evan C. Chen, MD2, Andrew A. Lane, MD, PhD12, Martha Wadleigh, MD2, Eric S. Winer, MD2, Richard M Stone, MD2, Daniel J. DeAngelo2, Amer M. Zeidan, MBBS, MHS13, Coleman Lindsley, MD, PhD2, Corey Cutler2 and Maximilian Stahl, MD14

1Brigham and Women's Hospital, Brookline, MA
2Dana-Farber Cancer Institute, Boston, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA
5Dana Farber Cancer Institute, Boston, MA
6Dana-Farber Cancer Inst. Brigham & Women's Hospital, Boston, MA
7Division of Hematology, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA
8Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
9Memorial Sloan Kettering Cancer Center, New York, NY
10Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
11University of Jordan, Amman, Jordan
12Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA
13Section of Hematology, Department of Internal Medicine, Yale University School of Medicine - Yale Cancer Center, New Haven, CT
14Dana Farber Institute, Boston, MA

Seonghan Lee*, Jae-Ho Yoon, MD and Seok Lee

Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

*signifies non-member of ASH